ITGB3 and central nervous system cancer: Survival analysis based on the expression of individual integrin genes (Fig. S1C) or a multigene signature (Fig. 1C) revealed that high levels of ITGAV, ITGB3 and ITGB5 correlate with a poor prognosis in glioma patients.